Patrick Healy
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 9
- Cancer Treatment and Pharmacology 8
- Genetics top 2%
- Glioma Diagnosis and Treatment 24
- Cancer Research top 5%
- Immunology top 5%
- Immunotherapy and Immune Responses 13
-
- Prostate Cancer Treatment and Research 34
- Prostate Cancer Diagnosis and Treatment 9
-
- Radiopharmaceutical Chemistry and Applications 13
- Co-authors
- James E. HerndonJohn H. SampsonLuis Sánchez-PérezAndrew J. ArmstrongDaniel J. GeorgeKristen A. BatichGary E. ArcherDuane A. Mitchell
- Cited by
- OncologyGeneticsCancer Research
- Journals
- Journal of Clinical Oncology (32 papers)Neuro-Oncology (9 papers)Clinical Cancer Research (6 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Patrick Healy
92 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 100
- Oncology 970
- Genetics 374
- Cancer Research 392
- Immunology 491
- Pulmonary and Respiratory Medicine 520
Countries citing papers authored by Patrick Healy
This map shows the geographic impact of Patrick Healy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Healy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Healy more than expected).
Fields of papers citing papers by Patrick Healy
This network shows the impact of papers produced by Patrick Healy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Healy. The network helps show where Patrick Healy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick Healy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2021 | 15 | |
| 3 | 2020 | 80 | |
| 4 | 2020 | 5 | |
| 5 | 2019 | 11 | |
| 6 | 2019 | 59 | |
| 7 | 2018 | 38 | |
| 8 | 2018 | 10 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 45 | |
| 11 | 2017 | 62 | |
| 12 | 2017 | 242 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 68 | |
| 15 | 2016 | 36 | |
| 16 | 2016 | 5 | |
| 17 | 2015 | 32 | |
| 18 | 2013 | 15 | |
| 19 | 2013 | 24 | |
| 20 | 2010 | 57 |
About Patrick Healy
Patrick Healy is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 98 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (34 papers), Glioma Diagnosis and Treatment (24 papers), Radiopharmaceutical Chemistry and Applications (13 papers), Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Prostate Cancer Diagnosis and Treatment (9 papers), CAR-T cell therapy research (9 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Oncology (970 citations), Genetics (374 citations), Cancer Research (392 citations), Immunology (491 citations) and Pulmonary and Respiratory Medicine (520 citations). Patrick Healy has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include James E. Herndon, John H. Sampson, Luis Sánchez-Pérez, Andrew J. Armstrong, Daniel J. George, Kristen A. Batich, Gary E. Archer, Duane A. Mitchell, Roger E. McLendon and Henry S. Friedman. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Clinical Cancer Research, Urologic Oncology Seminars and Original Investigations and Prostate Cancer and Prostatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.